Skip to main content
. 2021 Feb 14;11(2):124. doi: 10.3390/jpm11020124
ACEI angiotensin-converting enzyme inhibitor
AGTR2 angiotensin receptor type 2
BK bradykinin
BSA bovine serum albumin
CA4P combretastatin A4 phosphate
CO carbon monoxide
DMXAA 5,6-dimethylxanthenone-4-acetic acid
DOX doxorubicin
EC endothelial cell
ECM extracellular matrix
EGF epidermal growth factor
EGFR epidermal growth factor receptor
EPR enhanced permeability and retention
Et-A/B endothelin-A/B
FGF fibroblast growth factor
FLK1/KDR vascular endothelial growth factor receptor 2
FLT1 vascular endothelial growth factor receptor 1
GFNC gadofullerene nanocrystal
HDZ hydralazine
HGF hepatocyte growth factor
HIF hypoxia-inducible factor
HO heme oxygenase
131I iodine-131
ICAM-1 intercellular adhesion molecule-1
IFP interstitial fluid pressure
IL interleukin
iNOS inducible nitric oxide synthase
LLV leukolike vector
MMP matrix metalloproteinase
NO nitric oxide
NF-κB nuclear factor kappa-B
PDGF platelet-derived growth factor
PDGFR platelet-derived growth factor receptor
PEG polyethylene glycol
PLGF placenta growth factor
RGD arginylglycylaspartic acid
RNAi RNA interference
SDF-1 stromal cell-derived factor 1
sFLT1 soluble vascular endothelial growth factor receptor 1
shRNA short hairpin RNA
siRNA small interfering RNA
tetrac tetraiodothyroacetic acid
TGF-β transforming growth factor-β
TIMP tissue inhibitor of metalloproteinase
TME tumor microenvironment
TNF-α tumor necrosis factor-α
t-PA tissue plasminogen activator
VDA vascular disrupting agent
VEGF vascular endothelial growth factor
VEGFR vascular endothelial growth factor receptor
VPF vascular permeability factor